Chapter 12 deals with this topic [2] . 'Caring for patients who refuse blood' was published by the Royal College of Surgeons in 2016 [3] .
Why were these guidelines developed? 2 It should be clearly documented in the medical record which treatments and/or procedures the patient consents to and which they do not.
3 At least 6 weeks before elective surgery likely to be associated with significant blood loss, the patient's Hb should be checked and if < 130 g.l
À1
, optimisation by treatment with iron and/or erythropoietin should be considered.
4 All relevant issues should be highlighted at the time of the team briefing and during the surgical safety checklist before induction of anaesthesia. A specific checklist recording which components/products/ procedures the patient will or will not accept (as in Appendix S1) is important and should be available at the time of the WHO Surgical Safety checks in the operating theatre.
5
The majority of Jehovah's Witnesses will accept intraoperative CS -this should be discussed before surgery and if agreed set up from the start of surgery. Consent should be obtained.
6 The interventions promoted as part of a PBM approach should be rigorously applied, including tranexamic acid administration for major surgery.
7 After surgery, a comprehensive verbal and written handover of the patient is essential. Staff should be made aware of any adverse intra-operative events and should understand and respect the wishes of the patient that will have been discussed before the procedure.
Introduction
It has been 12 years since the last edition of this guideline was published [1] and much has changed, with advances in bloodless surgery and the development of alternatives to allogeneic blood transfusion. There has been an increased focus on the management of patients who refuse blood, including the Royal College of Surgeons' recently published good practice guide [3] . Patient autonomy and consent for medical treatments have been discussed increasingly in medicolegal fields with some pivotal cases of note since the last edition, including those relating to blood transfusion and capacity [5] .
There are a variety of reasons why patients choose not to accept blood components with the majority being due to religious beliefs or worries about the risks of allogeneic blood transfusion itself.
The principal aim of this publication is to provide a practical peri-operative guide for clinicians managing patients who refuse blood and a useful resource for patients who wish to invoke this right.
It has been produced through collaboration of a variety of professionals with medical representation from anaesthesia, paediatric anaesthesia, transfusion medicine and surgery, legal and patient representation from the Jehovah's Witnesses and other lay members.
Background to the beliefs of Jehovah's Witnesses regarding blood transfusion 'Each is the proper guardian of his own health, whether bodily or mental and spiritual. Mankind are the greater gainers by suffering each other to live as seems good to themselves, than by compelling each to live as seems good to the rest. ' -JOHN STUART MILL [6] A fundamental teaching of the faith of Jehovah's Witnesses is that life is sacred. 
Practical implications and terminology
Not all patients who refuse a blood transfusion are In the case of CS, the equipment can usually be set up as for non-Jehovah's Witness patients, that is, there is usually no requirement for a continuous connection from the patient to the CS system and back to the patient. This is a new recommendation, however, some patients may request, as a matter of personal preference, some form of continuous connectivity.
It should be clearly documented in the medical record to which treatments/procedures the patient consents and those to which they do not consent.
The importance of consent
It is a core ethical and legal principle in Great Britain and
Ireland that an adult with capacity has an absolute right to refuse treatment [8] . Although the legal frameworks differ, In England and Wales, an adult patient with capacity can make a legally binding advance decision to refuse specific medical treatment which would take effect if they have lost the capacity to consent to or refuse that treatment or those treatments. An advance decision to refuse lifesustaining treatment must be in writing, must be witnessed and must make clear that it is to apply to the treatment even if life is at risk. Ireland and the Republic of Ireland being subject to change at the time of writing [8] .
Treatment where the patient has lost capacity
In England and Wales, where a patient has lost capacity to accept or refuse treatment, then whether that treatment will be given depends on whether the patient has made an advance decision:
1 If the treatment falls fully within the terms of the advance decision, clinicians must respect its terms unless there is good evidence that the patient did not have capacity to make the advance decision, or that the patient has changed his/her mind since signing it. the purpose of any best interests decision is to make the decision that is right for that patient as an individual human being [10] . Even where a patient has not made an explicit advance decision, if it is known that the patient would have refused to give consent to a specific treatment, it is likely that provision of that treatment would not be in the patient's best interests, and therefore unlawful. [12] , laser transurethral prostatectomy (vs. standard transurethral prostatectomy) [13] and off-pump coronary artery bypass (vs. on-pump coronary artery bypass) [14] .
Patients may wish to be considered for referral to other centres where alternative techniques that they consider desirable are practised. 
Clinical management for elective surgery
This section will discuss the management of patients who refuse transfusion in whom major surgery is planned (defined as blood loss > 500 ml possible or likely). Most of the recommendations are included in PBM guidelines [15] .
Pre-operative
A pre-operative multidisciplinary discussion is mandatory, for planning purposes. This discussion should include, as a minimum, a senior surgeon, a senior anaesthetist and a senior haematologist. The Hospital Liaison Committee may also be consulted, with the patient's consent.
During the pre-admission phase, it is important to optimise red cell mass as much as possible to reduce the effect of bleeding and haemodilution on haemoglobin levels [16] . In most circumstances, surgery should be postponed until haemoglobin (Hb) levels have been optimised. It is also important to investigate any bleeding or , intravenous (i.v.) iron therapy should be administered [20] . The use of recombinant erythropoietin (EPO) together with i.v. iron therapy may also be considered if Hb < 130 g.l À1 and ferritin > 100 lg.l À1 [21, 22] . A checklist should be completed before admission to ensure pre-operative optimisation is complete (Online Supporting Information, Appendix S1).
Intra-operative
All relevant issues should be highlighted at the time of the team brief and during the surgical safety checklist before the start of anaesthesia. We recommend that the question 'is everyone aware of the answers to the blood transfusion checklist (Online Supporting Information, Appendix S2) and the techniques we will use to minimise blood loss in this case?' is added to the WHO Surgical Safety checklist for patients who refuse blood.
Consider acute normovolaemic haemodilution [23] ; blood is siphoned off by gravity into a collection bag containing anticoagulant, and replaced with crystalloid or colloid solution; if crystalloid is used it is likely that a larger volume will need to be administered than the volume of blood withdrawn in order to maintain normovolaemia.
Surgical blood loss, therefore, has a lower haematocrit and the blood removed from the patient is re-infused during or at the end of surgery. Local policy and guidelines should be in place for acute normovolaemic haemodilution.
Use paediatric blood sampling bottles or in-line patient monitoring if available. Point-of-care tests, for example, arterial or venous blood gas sampling and thromboelastometry/thromboelastography should be employed [24] . Controlled hypotension may be considered. Efforts should be made to maintain normothermia. Tranexamic acid should be administered intravenously and CS considered for all surgical procedures if blood loss >500 ml is possible/likely [25, 26] . In cancer surgery, a leucofilter should be used with CS.
If bleeding becomes clinically significant, the use of by increasing large vWF multimers, and possibly improving procoagulant platelet activity. Recombinant factor 7 should only be considered as a 'last resort' treatment due to the excess of prothrombotic events [27] .
Postoperative management
A comprehensive verbal and written handover of the patient to recovery, critical care and/or ward staff is essential. They should be made aware of any adverse intra-operative events and should understand and respect the wishes of the patient that have been discussed before the procedure.
Postoperative aims are to minimise ongoing blood loss, promote haemostasis, correct any coagulation defects and optimise oxygen delivery and consumption [28] . The need for each blood test should be carefully considered according to the individual clinical situation [29] . The volume of blood samples should be minimised by using paediatric sampling tubes if possible, and point-of-care testing should be available.
Following surgical procedures that employed a tourniquet intra-operatively there may be excessive blood loss after its release that may continue into the postoperative period. In these situations, postoperative CS can be employed. In case of bleeding, a postoperative dose of intravenous tranexamic acid (1 g) should be considered.
Children and adolescents
Children The likelihood that the court will overturn that refusal will diminish the closer the child is to age 18.
Scotland, Northern Ireland and the Republic of Ireland
The principles set out above by reference to the position in Safer, for everyone Every anaesthetist aims to keep their patients safe. We aim to safeguard every anaesthetist -by educating, supporting and inspiring them throughout their career.
We represent the life-changing, life-saving profession of anaesthesia -by supporting, informing and inspiring a worldwide community of over 11,000 members.
Our work and members span the globe, yet our voice is local and personal. We stay in close contact with our members, look after their day-to-day well being, and act as their champion.
Our world-class conferences, journals and online resources educate and inform, and our respected guidelines continually improve standards of patient safety.
We preserve and learn from the history of anaesthesia. We use that to inform the present, and facilitate vital research and innovation into its future.
As an independent organisation, we speak up freely and openly for the interests of anaesthetists and their patients. We influence policy, raise public awareness and are at the forefront of safer anaesthesia, across the world.
